Larry Fitzgerald praised Marvin Harrison Jr. at Kyler Murray's charity celebrity softball game, saying that the rookie ...

Scotiabank analyst Greg Harrison lowered the firm’s price target on Apellis (APLS) to $20 from $28 and keeps a Sector Perform rating on the shares.The company had a weak Q1, with Syfovre ...

Shares of Geron (NASDAQ:GERN) traded lower for the third straight session on Thursday as Scotiabank downgraded the U.S.

Board members Barbara Sykes, Rene Molenaur and the Rev. Greg Harrison voted against the agreement, arguing that Robinson had violated board policy and that $200,000 was too high a price for ...

Ratings for Vertex Pharmaceuticals VRTX were provided by 18 analysts in the past three months, showcasing a mix of bullish and bearish perspectives. The table below provides a snapshot of their ...

Analyst Greg Harrison from Scotiabank (TSX:BNS) adjusted the price target for Agios Pharma shares to $71 from $74, maintaining a Sector Outperform rating. The analyst noted a high likelihood of ...

The New York Jets released kicker Greg Zuerlein on Friday, an expected move as the team continues to get younger on its ...

Members of Congress have traded $VRTX stock 4 times in the past 6 months. Of those trades, 2 have been purchases and 2 have been sales. Here’s a breakdown of recent ...

Kambiz Yazdi: Thank you. Operator: Thank you. Our next question comes from the line of Greg Harrison of Scotiabank. Your line is now open. Greg Harrison: Hey, good morning, guys. Congrats on the ...

Scotiabank analyst Greg Harrison lowered the firm’s price target on Vera Therapeutics (VERA) to $55 from $60 and keeps an Outperform rating on the ...

Across the recent three months, 4 analysts have shared their insights on United Therapeutics (NASDAQ:UTHR), expressing a variety of opinions spanning from bullish to bearish. In the table below ...